Patent Assignment
Reel/Frame 024074/0196
Corrective Assignment to Correct the Us Application Number Recorded as 10/466879 to 12/369595 Previously Recorded on Reel 023951 Frame 0133. Assignor(S) Hereby Confirms the Assignment Should Be Recorded Against U.S. Application No. 12/369595 Which Is a Divisional Application of 10/466879.
Recorded: 2010-02-25
Pages: 6
Assignors
CHEN, GENHUI
Executed: 2003-12-08
WEBSTER, JOHN M.
Executed: 2003-12-08
LI, JIANXIONG
Executed: 2003-12-08
LIU, WEI
Executed: 2003-12-08
Assignee
WELICHEM BIOTECH INC.
4475 WAYBURNE DRIVE, SUITE 316, BUMABY, BC, V5G 3L1, CANADA
Covered Property
(1)
Novel 1,2-Diphenylethene Derivatives for Treatment of Immune Diseases
Related Assignments
(6)
Other recorded transfers of the patent in this record — the chain of ownership.
Corrective Assignment to Correct the Assignee's City of Residence. Document Previously Recorded at Reel 024074 Frame 0196. Assignor(S) Hereby Confirms the Correct Spelling of the Assignee's City of Residence as "Burnaby", as Indicated in the Assignment.
Apr 7, 2010
From: CHEN, GENHUI; WEBSTER, JOHN M.; LI, JIANXIONG; LIU, WEI
To: WELICHEM BIOTECH INC.
Reel/Frame 024346/0903 →
Assignment of Assignor's Interest
Aug 20, 2012
From: WELICHEM BIOTECH INC.
To: GLAXO GROUP LIMITED
Reel/Frame 028811/0458 →
Security Interest
Aug 24, 2018
From: DERMAVANT SCIENCES GMBH
To: NOVAQUEST CO-INVESTMENT FUND VIII, L.P.
Reel/Frame 046697/0848 →
Assignment of Assignor's Interest
Sep 6, 2018
From: GLAXO GROUP LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047028/0116 →
Intellectual Property Security Agreement
May 24, 2019
From: DERMAVANT SCIENCES GMBH
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 049285/0377 →
Release of Security Interest
Sep 3, 2024
From: HERCULES CAPITAL, INC., AS AGENT
To: DERMAVANT SCIENCES GMBH
Reel/Frame 068471/0692 →